Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Clonal evolution and immune evasion in posttransplantation relapses

Luca Vago

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 610–616.

https://doi.org/10.1182/hematology.2019000005

Published: 2019

Journal Articles

Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies

Richard J. Lin, Heidi D. Klepin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 59–62.

https://doi.org/10.1182/hematology.2019000076

Published: 2019

Journal Articles

Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice

Heidi D. Klepin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 53–58.

https://doi.org/10.1182/hematology.2019001299

Published: 2019

Journal Articles

Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care

Rebecca L. Olin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 63–70.

https://doi.org/10.1182/hematology.2019001300

Published: 2019

Journal Articles

Microbiota modification in hematology: still at the bench or ready for the bedside?

Christopher J. Severyn, Ryan Brewster, Tessa M. Andermann

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 303–314.

https://doi.org/10.1182/hematology.2019000365

Published: 2019

Journal Articles

Meeting the needs of CML patients in resource-poor countries

Hemant Malhotra, Jerald Radich, Pat Garcia-Gonzalez

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 433–442.

https://doi.org/10.1182/hematology.2019000050

Published: 2019

Journal Articles

Using genomics to define pediatric blood cancers and inform practice

Rachel E. Rau, Mignon L. Loh

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 286–300.

https://doi.org/10.1182/asheducation-2018.1.286

Published: 2018

Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 264–269.

https://doi.org/10.1182/asheducation-2018.1.264

Published: 2018

Journal Articles

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Daria V. Babushok

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 457–466.

https://doi.org/10.1182/asheducation-2018.1.457

Published: 2018

Journal Articles

The new tool “ KIT ” in advanced systemic mastocytosis

William Shomali, Jason Gotlib

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 127–136.

https://doi.org/10.1182/asheducation-2018.1.127

Published: 2018

Journal Articles

Shifting ground and gaps in transfusion support of patients with hematological malignancies

Christine Cserti-Gazdewich

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 553–560.

https://doi.org/10.1182/asheducation-2018.1.553

Published: 2018

Journal Articles

Aging, hematopoiesis, and the myelodysplastic syndromes

Stephen S. Chung, Christopher Y. Park

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 73–78.

https://doi.org/10.1182/asheducation-2017.1.73

Published: 2017

Journal Articles

What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?

Alessandro M. Vannucchi, Paola Guglielmelli

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 480–488.

https://doi.org/10.1182/asheducation-2017.1.480

Published: 2017

Journal Articles

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Andrew C. Dietz, Alan S. Wayne

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 708–715.

https://doi.org/10.1182/asheducation-2017.1.708

Published: 2017

Journal Articles

Graft versus tumor effects and why people relapse

J. H. Frederik Falkenburg, Inge Jedema

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 693–698.

https://doi.org/10.1182/asheducation-2017.1.693

Published: 2017

Journal Articles

New challenges in evaluating anemia in older persons in the era of molecular testing

David P. Steensma

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 67–73.

https://doi.org/10.1182/asheducation-2016.1.67

Published: 2016

Journal Articles

Discussing and managing hematologic germ line variants

Wendy Kohlmann, Joshua D. Schiffman

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 309–315.

https://doi.org/10.1182/asheducation-2016.1.309

Published: 2016

Journal Articles

The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adults

Sarah Nikiforow, Nancy Berliner

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 183–189.

https://doi.org/10.1182/asheducation-2015.1.183

Published: 2015

Journal Articles

When and why should patients with hematologic malignancies see a palliative care specialist?

Thomas W. LeBlanc, Areej El-Jawahri

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 471–478.

https://doi.org/10.1182/asheducation-2015.1.471

Published: 2015

Journal Articles

The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)

Luca Malcovati, Mario Cazzola

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 299–307.

https://doi.org/10.1182/asheducation-2015.1.299

Published: 2015

NARROW

Clonal evolution and immune evasion in posttransplantation relapses

Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies

Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice

Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care

Microbiota modification in hematology: still at the bench or ready for the bedside?

Meeting the needs of CML patients in resource-poor countries

Using genomics to define pediatric blood cancers and inform practice

Clinical consequences of clonal hematopoiesis of indeterminate potential

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

The new tool “ KIT ” in advanced systemic mastocytosis

Shifting ground and gaps in transfusion support of patients with hematological malignancies

Aging, hematopoiesis, and the myelodysplastic syndromes

What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Graft versus tumor effects and why people relapse

New challenges in evaluating anemia in older persons in the era of molecular testing

Discussing and managing hematologic germ line variants

The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adults

When and why should patients with hematologic malignancies see a palliative care specialist?

The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only